Tema ETFs’s BridgeBio Oncology BBOT Stock Holding History

Tema ETFs’s Portfolio BBOT Stock Details BBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$711K	Buy	93,339 +11,167	+14%	+$93.2K	0.02%	352
2026 Q1	$735K	Buy	+82,172	New	+$882K	0.05%	289

Tema ETFs's BBOT Position: Q2 2026 in Review

Tema ETFs increased its BridgeBio Oncology (BBOT) stake by 14% in Q2 2026, buying an estimated $93.2K and bringing the position to 93,339 shares worth $711K. The position accounts for 0.02% of the portfolio, ranked #352.

Tema ETFs first reported a position in BBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $735K in Q1 2026. 1 fund tracked by Wall St. Rank holds BBOT as of Q2 2026.

Tema ETFs held 93,339 shares of BridgeBio Oncology worth $711K as of Q2 2026.
Tema ETFs bought 11,167 BridgeBio Oncology shares in Q2 2026, an estimated $93.2K.
BridgeBio Oncology made up 0.02% of Tema ETFs's portfolio in Q2 2026, its #352 holding.
Tema ETFs first reported a position in BridgeBio Oncology in Q1 2026 and has held it in 2 quarters since.
Tema ETFs's BridgeBio Oncology position peaked at $735K in Q1 2026.
1 fund tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.